Pavion Blue Capital’s Merck MRK Stock Holding History

Pavion Blue Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$262K	Hold	2,179	–	–	0.11%	90
2025 Q4	$229K	Buy	+2,179	New	+$205K	0.1%	95
2025 Q1	–	Sell	-2,179	Closed	-$217K	–	105
2024 Q4	$217K	Hold	2,179	–	–	0.1%	95
2024 Q3	$247K	Sell	2,179 -99	-4%	-$11.8K	0.12%	93
2024 Q2	$282K	Hold	2,278	–	–	0.14%	80
2024 Q1	$301K	Sell	2,278 -72	-3%	-$8.88K	0.15%	77
2023 Q4	$256K	Hold	2,350	–	–	0.14%	82
2023 Q3	$242K	Sell	2,350 -10	-0.4%	-$1.08K	0.15%	85
2023 Q2	$272K	Hold	2,360	–	–	0.16%	80
2023 Q1	$251K	Hold	2,360	–	–	0.15%	85
2022 Q4	$262K	Hold	2,360	–	–	0.17%	80
2022 Q3	$203K	Hold	2,360	–	–	0.15%	85
2022 Q2	$215K	Buy	+2,360	New	+$209K	0.15%	84

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pavion Blue Capital's MRK Position: Q1 2026 in Review

Pavion Blue Capital held its Merck (MRK) position steady in Q1 2026 at 2,179 shares worth $262K. The position accounts for 0.11% of the portfolio, ranked #90.

Pavion Blue Capital first reported a position in MRK in Q2 2022 and has held it in 13 quarters since. The position peaked at $301K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Pavion Blue Capital held 2,179 shares of Merck worth $262K as of Q1 2026.
Pavion Blue Capital left its Merck share count unchanged in Q1 2026.
Merck made up 0.11% of Pavion Blue Capital's portfolio in Q1 2026, its #90 holding.
Pavion Blue Capital first reported a position in Merck in Q2 2022 and has held it in 13 quarters since.
Pavion Blue Capital's Merck position peaked at $301K in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.